An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

--Assembly Biosciences, Inc., a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the first participant has been dosed in the Phase 1 ...